BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28739859)

  • 1. Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors.
    Huang MN; Yu W; Teoh WW; Ardin M; Jusakul A; Ng AWT; Boot A; Abedi-Ardekani B; Villar S; Myint SS; Othman R; Poon SL; Heguy A; Olivier M; Hollstein M; Tan P; Teh BT; Sabapathy K; Zavadil J; Rozen SG
    Genome Res; 2017 Sep; 27(9):1475-1486. PubMed ID: 28739859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
    Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
    Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
    Shen HM; Ong CN
    Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational spectra of aflatoxin B
    Chawanthayatham S; Valentine CC; Fedeles BI; Fox EJ; Loeb LA; Levine SS; Slocum SL; Wogan GN; Croy RG; Essigmann JM
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3101-E3109. PubMed ID: 28351974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma.
    Rieswijk L; Claessen SM; Bekers O; van Herwijnen M; Theunissen DH; Jennen DG; de Kok TM; Kleinjans JC; van Breda SG
    Toxicology; 2016 Mar; 350-352():31-9. PubMed ID: 27153756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of mutations in the p53 tumor suppressor gene in woodchuck hepatocellular carcinomas associated with hepadnavirus infection and intake of aflatoxin B1.
    Rivkina M; Cote PJ; Robinson WS; Tennant BC; Marion PL
    Carcinogenesis; 1996 Dec; 17(12):2689-94. PubMed ID: 9006107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
    Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
    Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct.
    Lin YC; Li L; Makarova AV; Burgers PM; Stone MP; Lloyd RS
    Carcinogenesis; 2014 Jul; 35(7):1461-8. PubMed ID: 24398669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action.
    Moore MM; Schoeny RS; Becker RA; White K; Pottenger LH
    Crit Rev Toxicol; 2018 Apr; 48(4):312-337. PubMed ID: 29431554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
    Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
    Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic variation of p53 mutational profile in nonmalignant human liver.
    Aguilar F; Harris CC; Sun T; Hollstein M; Cerutti P
    Science; 1994 May; 264(5163):1317-9. PubMed ID: 8191284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua.
    Lin YC; Li L; Makarova AV; Burgers PM; Stone MP; Lloyd RS
    J Biol Chem; 2014 Jun; 289(26):18497-506. PubMed ID: 24838242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.
    Yao JG; Huang XY; Long XD
    Int J Clin Exp Pathol; 2014; 7(9):6231-44. PubMed ID: 25337275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico.
    Lino-Silva LS; Lajous M; Brochier M; Santiago-Ruiz L; Melchor-Ruan J; Xie Y; Wang M; Wu D; Higson H; Jones K; Romero-Martínez M; Villalpando S; Mohar A; Smith JW; Alvarez CS; McGlynn KA; Dean M; Groopman J
    Salud Publica Mex; 2022 Feb; 64(1):35-40. PubMed ID: 35438902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.